The Unique Role of the Oncology Nurse in the Targeted Treatment Era of Breast Cancer
FACULTY
Marilyn Douglas, MSN, FNP-BC, OCN
Director of Advanced Practice, Oncology
Laura and Isaac Perlmutter Cancer Center
New York, NY
PROGRAM OVERVIEW
This enduring activity is focused on use of biologics and targeted therapies in the management of breast cancer.
TARGET AUDIENCE
This initiative is designed to meet the educational needs of oncologists and oncology nurses involved in the management of patients with breast cancer.
LEARNING OBJECTIVES
Upon completion of this activity, participants will be able to:
Describe the antitumorigenic mechanisms of the CDK 4/6 inhibitors in hormone receptor-positive breast cancer
Discuss the CDK 4/6 inhibitor clinical trial data for patients with HR+, HER-2 negative advanced breast cancer across multiple lines of therapy
Review the oncology nurses roles in the recognition of breast cancer treatment related adverse events while optimizing patient medication persistence
Explain the patient’s and healthcare team’s responsibilities to optimize outcomes through ongoing education and communication to support adherence to oral cancer treatments
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Marilyn Johnston has nothing to disclose.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Ana Goffin, MPA, Program Manager for Med Learning Group has nothing to disclose.
Nina Oshiokpekhai MS, PharmD, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture Ms. Johnston may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.
You will receive your certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement
information at http://medlearninggroup.com/privacy‐policy/
RELEASE DATE: January 10, 2019
EXPIRATION DATE: January 10, 2020
